Daily Anesthesiology Research Analysis
Analyzed 129 papers and selected 3 impactful papers.
Summary
Three high-impact studies advance anesthesiology-adjacent science and practice: (1) a Nature Neuroscience study reveals that dural venous outflow governs intracranial pressure and brain clearance via meningeal lymphatic vessels; (2) a Molecular Psychiatry single-nucleus transcriptomic study implicates hippocampal excitation–inhibition imbalance in perioperative neurocognitive disorders; and (3) a Science Advances paper identifies an LPA/LPAR→ERK→PIEZO2 pathway driving temporomandibular disorder-like pain, highlighting new analgesic targets.
Research Themes
- Venous outflow, meningeal lymphatics, and intracranial pressure physiology
- Excitation–inhibition balance and perioperative neurocognitive disorders
- Lipid signaling and mechanotransduction in pain (LPA/LPAR–PIEZO2 axis)
Selected Articles
1. Cerebral venous blood flow regulates intracerebral pressure and brain clearance via meningeal lymphatic vessels.
In IIH patients, dural venous sinus stenoses correlated with altered perivenous fluid patterns and brain edema. In mice, jugular vein ligation induced transient intracerebral hypertension, edema, and impaired clearance, worsened by meningeal lymphatic vessel (MLV) depletion; only MLV-intact animals restored clearance. These data implicate venous flow–MLV coupling as a controller of intracerebral pressure and brain clearance.
Impact: This study reframes intracranial pressure physiology by linking venous outflow to meningeal lymphatic function, offering mechanistic rationale for venous stenting and lymphatic-targeted therapies.
Clinical Implications: For neuroanesthesiology and neurocritical care, assessment of venous outflow and preservation of meningeal lymphatic function may be crucial in IIH and intracranial hypertension management; it supports physiologic rationale for venous stenting and motivates research into lymphatic-modulating strategies.
Key Findings
- In IIH, dural venous sinus stenoses were associated with altered perivenous fluid patterns and brain edema on MRI.
- Jugular vein ligation in mice caused transient intracerebral hypertension, edema, and impaired brain fluid clearance.
- Meningeal lymphatic vessel depletion elevated intracerebral pressure and prevented clearance recovery after venous ligation, implicating MLVs in ICP control.
Methodological Strengths
- Translational approach integrating human MRI with mechanistic mouse models
- Causal interrogation via MLV depletion to test ICP and clearance effects
Limitations
- Human sample size and generalizability are not specified in the abstract
- Mouse jugular ligation may not capture all aspects of human IIH pathophysiology
Future Directions: Prospective clinical studies quantifying venous outflow, MLV structure/function, and intracranial pressure dynamics; interventional trials testing lymphatic-modulating or venous-targeted therapies.
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure and dural venous sinus stenoses, which can be relieved by venous stenting. Here we investigated whether venous blood flow may play a role in controlling brain pressure. Using magnetic resonance imaging in patients with IIH and healthy controls, we identified that dural venous stenoses in IIH were associated with alterations of the perivenous fluid pattern and brain edema. We developed a mouse model of jugular vein ligation (JVL), which developed transient intracerebral hypertension, brain edema and impaired brain clearance, along with defective meningeal lymphatic vessels (MLVs). MLV depletion increased intracerebral pressure in control and JVL mice, but only MLV-deficient ligated mice failed to restore brain fluid clearance. These findings implicate MLVs in the control of intracerebral pressure and establish the dural venous sinuses as critical platforms where venous flow directs MLVs to ensure brain fluid clearance.
2. Excitation-inhibition imbalance underlies perioperative neurocognitive disorders: a single-nucleus transcriptomic perspective in mice hippocampus.
Single-nucleus RNA-seq of 119,109 hippocampal cells from aged mouse PND models revealed excitation–inhibition imbalance with impaired inhibitory control of excitatory plasticity. Distinct astrocyte and oligodendrocyte states linked to E/I imbalance were identified, suggesting multicellular contributions to PND pathogenesis.
Impact: Defines a cellular–molecular framework for PND centered on E/I imbalance, guiding biomarker discovery and mechanism-based interventions relevant to anesthesiology.
Clinical Implications: Motivates perioperative strategies to preserve inhibitory tone and synaptic balance (e.g., choice/dose of anesthetics, analgesics), and development of E/I-targeted therapeutics and biomarkers for cognitive risk stratification.
Key Findings
- Single-nucleus RNA-seq (119,109 cells) from aged mouse hippocampus shows E/I imbalance with dysregulated inhibitory control of excitatory plasticity in PND.
- Distinct PND-associated astrocyte and oligodendrocyte phenotypes—different from other cognitive disorders—link glial states to E/I imbalance.
- Electrophysiology and protein assays support transcriptomic findings, indicating convergent mechanistic evidence.
Methodological Strengths
- Large-scale single-nucleus transcriptomics in aged animals relevant to clinical demographics
- Convergent validation with electrophysiology and Western blotting
Limitations
- Mouse-based model without human validation in this study
- Causality for specific cellular targets remains to be established in vivo
Future Directions: Translate signatures to human perioperative cohorts; test interventions restoring E/I balance (e.g., GABAergic modulators) and evaluate anesthetic regimens for cognitive protection.
Perioperative neurocognitive disorders (PND), highly prevalent in geriatric surgical populations, constitute a major postoperative clinical challenge associated with prolonged hospital stays and adverse surgical outcomes. Although substantial research efforts have been devoted to investigating etiology, the precise molecular mechanisms of PND remains elusive, thereby hindering the development of effective therapeutic interventions. To address this gap, we conducted single-nucleus RNA sequencing on 119,109 hippocampal cells isolated from 18-month-old PND mice and age-matched controls, alongside performing complementary Western blotting and electrophysiological experiments. We propose that hippocampal neuronal excitation-inhibition (E/I) imbalance serves as a key mechanism underlying PND, which is associated with dysregulated inhibitory control of excitatory plasticity in PND pathology. Furthermore, we identified PND-associated astrocytes and oligodendrocytes-distinct from those in other cognitive disorders and linked to E/I imbalance. These cell types played distinct roles in the pathological process of PND. Our study proposes that E/I imbalance, associated with dysregulated inhibitory control of excitatory plasticity, underlies the pathogenesis of PND, providing new insights for therapeutic interventions.
3. LPA/LPAR signaling drives temporomandibular disorders-like pain through regulating the expression and sensitization of PIEZO2.
LPA is elevated in TMD models and in patient blood, correlating with pain. LPAR1/3 in trigeminal neurons drive TMD-like pain by ERK-dependent upregulation and sensitization of the mechanotransducer PIEZO2; genetic or pharmacologic inhibition of LPARs, ERK, or PIEZO2 mitigates pain.
Impact: Identifies a lipid–mechanotransduction pathway (LPA/LPAR–ERK–PIEZO2) as a driver of TMD-like pain across species, nominating multiple druggable nodes for non-opioid analgesia.
Clinical Implications: Suggests therapeutic development of LPAR1/3 antagonists, ERK pathway modulators, or PIEZO2 blockers for refractory orofacial pain; supports biomarker work using circulating LPA for patient stratification.
Key Findings
- LPA levels were elevated in mouse TMD-like pain models and in TMD patient blood, correlating with pain intensity.
- LPAR1 and LPAR3 were expressed in mouse and human trigeminal neurons and upregulated in TMD-like pain; inhibition/knockout of LPAR1/3 attenuated pain.
- LPA/LPAR signaling increased and sensitized PIEZO2 via ERK in trigeminal neurons; blocking PIEZO2 or ERK reduced TMD-like pain.
Methodological Strengths
- Cross-species validation including human patient samples and mouse models
- Genetic and pharmacologic perturbations establishing pathway causality (LPARs, ERK, PIEZO2)
Limitations
- Patient sample size and clinical heterogeneity are not detailed in the abstract
- Translational safety/efficacy of targeting PIEZO2 or ERK in humans remains to be established
Future Directions: Early-phase trials of LPAR1/3 antagonists and exploration of PIEZO2/ERK modulators in TMD; validation of circulating LPA as a diagnostic/prognostic biomarker.
Temporomandibular disorders (TMD) pain is the most common orofacial pain with limited effective treatments. Here, we observed elevated lysophosphatidic acid (LPA), a bioactive lipid, in blood, trigeminal ganglion (TG), and peri-temporomandibular joint (TMJ) tissues in mouse models of TMD-like pain induced by TMJ inflammation or masseter muscle injury. Notably, LPA levels were also elevated in TMD patients' blood and positively correlated with their pain intensity. LPA receptors (LPAR) 1 and 3 were expressed in mouse and human TG neurons and upregulated in TMD-like pain models. Inhibition or knockout of LPAR1 or LPAR3 attenuated TMD-like pain, while LPA injection into the TMJ or masseter muscle evoked pain. Furthermore, we demonstrated that LPA/LPAR signaling upregulates and sensitizes PIEZO2, a mechanosensitive ion channel, in TG neurons via extracellular signal-regulated kinase (ERK). Specific deletion or inhibition of PIEZO2 and suppression of ERK activation in TG neurons mitigated TMD-like pain. These findings suggest that LPA/LPAR signaling drives TMD-like pain via PIEZO2, offering potential therapeutic targets.